Health Care & Life Sciences » Pharmaceuticals | Samsung Pharmaceutical Co. Ltd.

Samsung Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
18,488,789.50
23,748,181.10
994,391.80
21,617,603.30
7,273,961.10
2,075,706
Depreciation, Depletion & Amortization
1,376,199.00
1,473,441.80
2,478,970.10
4,266,778.00
3,915,317.80
3,764,058
Other Funds
2,425,692.80
-
-
-
-
1,382,282.80
Funds from Operations
4,477,086.30
531,161.10
654,006.90
7,499,844.90
189,764.30
306,069.20
Changes in Working Capital
5,080,740.80
13,052,173.90
3,550,942.40
2,441,536.20
4,962,632.70
6,826,597
Net Operating Cash Flow
603,654.50
13,583,335.00
4,204,949.30
9,941,381.10
5,152,397.00
6,520,527.80
Capital Expenditures
2,077,759.50
2,092,133.90
17,605,933.40
34,341,815.60
6,387,012.40
Sale of Fixed Assets & Businesses
-
3,537,136.40
6,557.20
75,028.90
330,800.00
Purchase/Sale of Investments
87,340.40
-
3,788,331.60
8,537,787.50
400,000.00
Net Investing Cash Flow
1,990,419.10
1,453,740.00
51,508,699.70
28,343,291.20
22,258,950.50
Issuance/Reduction of Debt, Net
8,001,238.40
12,816,686.30
54,322,262.30
16,726,819.30
19,413,696.80
Net Financing Cash Flow
6,573,217.40
14,933,264.80
71,277,702.80
24,083,156.50
19,413,696.80
Net Change in Cash
7,959,982.00
2,803,669.80
16,475,166.00
14,201,515.80
2,307,143.30
Free Cash Flow
1,214,784.20
15,673,826.40
16,066,937.70
43,177,105.40
956,005.30
Net Assets from Acquisitions
-
99,995.00
3,700,000.00
-
4,000,000.00
Other Sources
-
293,967.60
374,672.70
6,491,220.00
1,076,099.00
Change in Capital Stock
997,671.70
27,749,951.20
16,955,440.50
40,809,975.80
-
Exchange Rate Effect
-
-
911,112.10
-
-
Other Uses
-
185,235.00
26,795,664.50
9,105,512.00
13,678,837.10

About Samsung Pharmaceutical Co.

View Profile
Address
35 Jeyakgongdan 2-gil
Hwaseong-si GY 18622
Korea, Republic Of
Employees -
Website http://www.sspharm.co.kr
Updated 07/08/2019
Samsung Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. It operates through the following business divisions: Pharmaceutical, Cosmetics, and Healthy Food. The Pharmaceutical divsion provides medicines for digestion, antibiotics, intestine, alleviation of fever, and cerebral apoplexy.